SNZZF (Senzime AB) Short Interest


SNZZF Senzime AB SNZZF
68 GF Score
Price $0.48
GF Value $1.21
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Senzime AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SNZZF vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Senzime AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senzime AB Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Senzime AB's Short Interest falls into.


SNZZF
68GF Score
Senzime AB SNZZF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Senzime AB (SNZZF) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of $0.48 is trading 60.5% below its estimated GF Value™ of $1.21. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for SNZZF:

  • Short Interest:
  • GF Value™: $1.21 vs. price of $0.48 (60.5% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the SNZZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senzime AB Business Description

Other Exchanges SEZI:Sweden6YC:Germany
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
68GF Score

Get the complete analysis for SNZZF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price
$1.21
GF Value